Document is current
Any future updates will be listed below
-
Authors
Raymundi, Ana Maria https://orcid.org/0000-0002-8012-4104
Cardoso, Nathalie Carla
Lourenço, Gabriel Costa https://orcid.org/0009-0009-6465-6707
Queiroz, Ruliam
Dolzan, Maressa D.
Vitali, Luciano
Meyer, Erika https://orcid.org/0000-0002-8425-6358
Lisboa, Sabrina Francesca https://orcid.org/0000-0002-2069-3524
Guimarães, Francisco Silveira https://orcid.org/0000-0003-4092-7778
Pinna, Graziano https://orcid.org/0000-0001-7541-4855
Bertoglio, Leandro José https://orcid.org/0000-0003-2876-1146
Stern, Cristina Aparecida Jark https://orcid.org/0000-0002-1736-5503
- License Information
-
More Information
Article History
Received: 27 October 2025
Revised: 18 April 2026
Accepted: 22 April 2026
First Online: 9 May 2026
Competing interests
: G.P. has a patent application on N-palmitoylethanolamine (PEA) and peroxisome proliferator-activated receptor alpha (PPAR-α) agonists for the treatment of neuropsychiatric disorders (US20180369171A1), allowed on 16 May 2023. The other authors declare no competing interests.
